DRUG FIRMS SAY CLINTON PLAN WILL SHIFT REVENUE TO GENERICS

DRUG FIRMS SAY CLINTON PLAN WILL SHIFT REVENUE TO GENERICS

President Clinton's health-care reform plan would shift revenue from research-based companies making